| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Eduardo Davila | |
| Joseph R Scalea | |||
| Jonathan S Bromberg | |||
| Young Suk Lee | |||
| P2860 | cites work | Binding of paxillin to alpha4 integrins modifies integrin-dependent biological responses | Q22010953 |
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
| Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards | Q26744395 | ||
| Myeloid-Derived Suppressor Cells in Bacterial Infections | Q26749373 | ||
| Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms | Q26751022 | ||
| Regulatory myeloid cells in transplantation | Q26999875 | ||
| Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences | Q27027064 | ||
| The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation | Q28077757 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| A fragment of paxillin binds the alpha 4 integrin cytoplasmic domain (tail) and selectively inhibits alpha 4-mediated cell migration | Q28210855 | ||
| The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment | Q28388630 | ||
| Coordinated regulation of myeloid cells by tumours | Q28395157 | ||
| CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis | Q28587371 | ||
| An overview of the necessary thymic contributions to tolerance in transplantation | Q30275198 | ||
| Myeloid-derived suppressor cells: the dark knight or the joker in viral infections? | Q30411008 | ||
| M-CSF instructs myeloid lineage fate in single haematopoietic stem cells | Q30540578 | ||
| Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. | Q33564156 | ||
| Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development | Q84303859 | ||
| The cam-path forward | Q85491670 | ||
| Innate immune cell collaborations instigate transplant tolerance | Q85775603 | ||
| Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation | Q86763876 | ||
| Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses | Q88012863 | ||
| Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function | Q89776979 | ||
| CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection | Q45869335 | ||
| TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors | Q45877917 | ||
| Granulocytic Myeloid-Derived Suppressor Cells Accumulate in Human Placenta and Polarize toward a Th2 Phenotype. | Q46617657 | ||
| CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress | Q46925832 | ||
| Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in mice | Q47910452 | ||
| Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease. | Q48294132 | ||
| C-C Chemokine Receptor Type 2-Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants | Q48592633 | ||
| Comparative Study of the Immunoregulatory Capacity of In Vitro Generated Tolerogenic Dendritic Cells, Suppressor Macrophages, and Myeloid-Derived Suppressor Cells | Q49035033 | ||
| TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide. | Q50924516 | ||
| Suppression of CD3/CD28 antibody stimulated responses by human granulocytic myeloid-derived suppressor cells: fact or artefact? | Q50945764 | ||
| SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells. | Q51069953 | ||
| Inflammation, but not recruitment, of adipose tissue macrophages requires signalling through Mac-1 (CD11b/CD18) in diet-induced obesity (DIO). | Q51276232 | ||
| CD66b regulates adhesion and activation of human eosinophils. | Q52583803 | ||
| Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion. | Q53087524 | ||
| The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice. | Q53106855 | ||
| Efficacy of Myeloid Derived Suppressor Cells on Transplant Survival. | Q53380753 | ||
| Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells. | Q54273932 | ||
| Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen. | Q54411021 | ||
| Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. | Q54421148 | ||
| B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. | Q54516012 | ||
| Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 | ||
| Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma | Q59245171 | ||
| Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells | Q59617808 | ||
| Development of tolerance to class II-mismatched renal transplants after a short course of cyclosporine therapy in miniature swine | Q72422829 | ||
| CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis | Q73719540 | ||
| Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance | Q80358513 | ||
| CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates | Q80444346 | ||
| Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion | Q81394821 | ||
| Spontaneous operational tolerance in kidney transplant recipients | Q83450310 | ||
| Endogenous glucocorticoids promote the expansion of myeloid-derived suppressor cells in a murine model of trauma | Q84290586 | ||
| Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine | Q33584867 | ||
| HLA-mismatched renal transplantation without maintenance immunosuppression | Q33640791 | ||
| The innate immune system in allograft rejection and tolerance | Q33732470 | ||
| IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus | Q33744083 | ||
| Evaluation of the therapeutic potential of bone marrow-derived myeloid suppressor cell (MDSC) adoptive transfer in mouse models of autoimmunity and allograft rejection | Q33754157 | ||
| Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling | Q33772651 | ||
| Critical roles of lysosomal acid lipase in myelopoiesis | Q33816409 | ||
| Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice | Q33968062 | ||
| Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes | Q33978763 | ||
| Development of antidonor antibody directed toward non-major histocompatibility complex antigens in tolerant animals | Q34111522 | ||
| S100A9 a new marker for monocytic human myeloid-derived suppressor cells. | Q34150479 | ||
| Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. | Q34287902 | ||
| Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance | Q34381246 | ||
| Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors. | Q34412887 | ||
| Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. | Q34496604 | ||
| Transplantation tolerance from a historical perspective | Q34572212 | ||
| IL-6 promotes cardiac graft rejection mediated by CD4+ cells | Q35566506 | ||
| Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis. | Q35571279 | ||
| Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice | Q35648172 | ||
| Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates | Q35680600 | ||
| The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity | Q35750663 | ||
| Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants | Q35918706 | ||
| CD14 Is a Co-Receptor for TLR4 in the S100A9-Induced Pro-Inflammatory Response in Monocytes | Q36030737 | ||
| MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis | Q36229458 | ||
| Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer | Q36260673 | ||
| Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. | Q36432026 | ||
| mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors | Q36527132 | ||
| Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression | Q36738775 | ||
| Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells | Q36742588 | ||
| Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. | Q37151168 | ||
| Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts | Q37157534 | ||
| Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis | Q37200858 | ||
| Minimization of immunosuppression after lung transplantation: current trends | Q37279359 | ||
| Critical role of the mTOR pathway in development and function of myeloid-derived suppressor cells in lal-/- mice | Q37530775 | ||
| Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes | Q37544847 | ||
| Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function | Q37637739 | ||
| A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells | Q37681196 | ||
| Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways | Q37692764 | ||
| Subsets, expansion and activation of myeloid-derived suppressor cells | Q37727050 | ||
| The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury | Q37745582 | ||
| Myeloid derived suppressor cells in transplantation. | Q37908629 | ||
| Myeloid-derived suppressor cells in transplantation and cancer | Q38005601 | ||
| Amino acid metabolism related to immune tolerance by MDSCs | Q38010200 | ||
| On the armament and appearances of human myeloid-derived suppressor cells | Q38031742 | ||
| Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives | Q38047050 | ||
| Immunoregulatory properties of rapamycin-conditioned monocyte-derived dendritic cells and their role in transplantation | Q38078123 | ||
| Induction of tolerance through mixed chimerism | Q38175306 | ||
| Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells | Q38192184 | ||
| Epigenetic control of myeloid cell differentiation, identity and function. | Q38298238 | ||
| Now or never? The case for cell-based immunosuppression in kidney transplantation. | Q38367524 | ||
| Mechanistic similarities between trauma, atherosclerosis, and other inflammatory processes | Q38573270 | ||
| New insights into myeloid-derived suppressor cells and their roles in feto-maternal immune cross-talk | Q38645294 | ||
| Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer | Q39188755 | ||
| IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer | Q39613201 | ||
| Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells | Q39876369 | ||
| Monocyte migration to inflamed skin and lymph nodes is differentially controlled by L-selectin and PSGL-1. | Q40135661 | ||
| Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study | Q40148008 | ||
| Does placental MDSC-mediated modulation of arginine levels help protect the foetus from auxotrophic pathogens? | Q40219365 | ||
| Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype | Q40229629 | ||
| Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation | Q40348056 | ||
| Myeloid-Derived Suppressor Cells | Q40385399 | ||
| CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells | Q40833951 | ||
| The roles of sepsis-induced myeloid derived suppressor cells in mice corneal, skin and combined transplantation. | Q40844463 | ||
| CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population | Q40895291 | ||
| Effects of Adoptive Transferring Different Sources of Myeloid-Derived Suppressor Cells in Mice Corneal Transplant Survival. | Q41054503 | ||
| CD15 expression in human myeloid cell differentiation is regulated by sialidase activity | Q41145573 | ||
| Tolerance and immune suppression in the tumor microenvironment | Q41379079 | ||
| The induction of tolerance of renal allografts by adoptive transfer in miniature swine | Q41483293 | ||
| Maternal anti-placental cell-mediated reactivity and spontaneous abortions | Q41535737 | ||
| The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages | Q41623216 | ||
| Th1-type immunity is incompatible with successful pregnancy | Q41632972 | ||
| Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells | Q41729534 | ||
| DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance | Q41925366 | ||
| Abrogation of renal allograft tolerance in MGH miniature swine: the role of intra-graft and peripheral factors in long-term tolerance. | Q42073605 | ||
| The terminology issue for myeloid-derived suppressor cells | Q42425163 | ||
| Tolerance to class I-disparate renal allografts in miniature swine. Maintenance of tolerance despite induction of specific antidonor CTL responses. | Q42691510 | ||
| Preparation and characterization of monoclonal antibodies reactive with porcine PBL. | Q42823612 | ||
| IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice | Q44259082 | ||
| Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells. | Q44751816 | ||
| Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs | Q45236041 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 359-367 | |
| P577 | publication date | 2017-11-20 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation | |
| P478 | volume | 102 |
| Q90051384 | Granulocyte Colony-Stimulating Factor Attenuates Renal Ischemia-Reperfusion Injury by Inducing Myeloid-Derived Suppressor Cells |
| Q90185646 | Impact of infection on transplantation tolerance |
| Q88870841 | Monocytic myeloid-derived suppressor cells generated from rhesus macaque bone marrow enrich for regulatory T cells |
| Q64954875 | Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity. |
| Q91719323 | Myeloid-derived suppressor cells are bound and inhibited by anti-thymocyte globulin |
| Q47706581 | Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy. |
| Q90601904 | The Effect of Immunosuppressive Drugs on MDSCs in Transplantation |
Search more.